CollPlant granted patent for photocurable dermal filler product candidate

CollPlant (CLGN) announced it has been granted U.S. Patent No. 12,186,449 related to its photocurable dermal filler product candidate. The patent relates to polymerizable solutions that are comprised of modified recombinant human collagen and other constituents such as hyaluronic acid. The patent will expire on May 2, 2039.